Clinical trial
Effect of a Mixture of Probiotics ( Lactobacillus Gasseri PA16/8,Bifidobacterium Longum SP07/3, Bifidobacterium Bifidum MF 20/5) on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adult
NCT01652066 is registered in ClinicalTrials.gov with Merck Medication Familiale as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of a Mixture of Probiotics ( Lactobacillus Gasseri PA16/8,Bifidobacterium Longum SP07/3, Bifidobacterium Bifidum MF 20/5) on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adult
- Lead sponsor
- Merck Medication Familiale
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- December 31, 2011
- Enrollment
- 430 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
enhancement of protective antibody response after probiotic consumption